Forte Biosciences, Inc. Profile Avatar - Palmy Investing

Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas,…

Biotechnology
US, Dallas [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Forte Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of FBRX's Analysis
CIK: 1419041 CUSIP: 34962G109 ISIN: US34962G1094 LEI: - UEI: -
Secondary Listings
FBRX has no secondary listings inside our databases.